High, Wide and Handsome- A Review of Wildlife and Aquatic Crossing Technology Over the Last

Ten years ago, at the 2001 International Conference on Ecology and Transportation in Keystone, Colorado, Ruediger (2001) presented a paper entitled High, Wide and Handsome: Designing More Effective Wildlife and Fish Crossings for Roads and Highways. At the time (2001), the paper provided a biologists perspective of how wildlife and fish crossing should be designed. Since that time, hundreds of wildlife and aquatic crossings have been built, monitored and researched. The authors will explore how wildlife and aquatic organism crossing knowledge has evolved from 2001 to 2011. The authors will explore how monitoring and research information gained over the last decade on structure height and width requirements, bottom material, location and structure type has modified current wildlife and aquatic crossing design. Information on noise impacts, moisture content of soil, light, human activities and vegetation associations relative to structure designs will be updated. Also, use of structures by elk (Cervus elaphus), deer (Odocoileus spp), moose (Alces alces), antelope (Antilocarpra americana), bighorn sheep (Ovis canadensis) and various carnivores will be discussed based on current knowledge. The information presented will help transportation agencies, wildlife agencies and land management agencies design crossing structures that are effective in reducing animal-vehicle collisions, improving habitat and population connectivity, and are cost-effective. The authors have been involved with over 100 major wildlife and aquatic highway crossings in North America, particularly in the Rocky Mountain States, and have extensive experience in structure location, design, costs and the interagency coordination required to implement effective highway mitigation

The smooth cyclotron line in Her X-1 as seen with NuSTAR

Her X-1, one of the brightest and best studied X-ray binaries, shows a cyclotron resonant scattering feature (CRSF) near 37 keV. This makes it an ideal target for detailed study with the Nuclear Spectroscopic Telescope Array (NuSTAR), taking advantage of its excellent hard X-ray spectral resolution. We observed Her X-1 three times, coordinated with Suzaku, during one of the high flux intervals of its 35d super-orbital period. This paper focuses on the shape and evolution of the hard X-ray spectrum. The broad-band spectra can be fitted with a powerlaw with a high-energy cutoff, an iron line, and a CRSF. We find that the CRSF has a very smooth and symmetric shape, in all observations and at all pulse-phases. We compare the residuals of a line with a Gaussian optical depth profile to a Lorentzian optical depth profile and find no significant differences, strongly constraining the very smooth shape of the line. Even though the line energy changes dramatically with pulse phase, we find that its smooth shape does not. Additionally, our data show that the continuum is only changing marginally between the three observations. These changes can be explained with varying amounts of Thomson scattering in the hot corona of the accretion disk. The average, luminosity-corrected CRSF energy is lower than in past observations and follows a secular decline. The excellent data quality of NuSTAR provides the best constraint on the CRSF energy to date.Comment: 13 pages, 13 figures, accepted for publication in Ap

An Isosurface Continuity Algorithm for Super Adaptive Resolution Data

We present the chain-gang algorithm for isosurface rendering of super adaptive resolution (SAR) volume data in order to minimize (1) the space needed for storage of both the data and the isosurface and (2) the time taken for computation. The chain-gan

Structural Basis of PP2A Inhibition by Small t Antigen

The SV40 small t antigen (ST) is a potent oncoprotein that perturbs the function of protein phosphatase 2A (PP2A). ST directly interacts with the PP2A scaffolding A subunit and alters PP2A activity by displacing regulatory B subunits from the A subunit. We have determined the crystal structure of full-length ST in complex with PP2A A subunit at 3.1 Å resolution. ST consists of an N-terminal J domain and a C-terminal unique domain that contains two zinc-binding motifs. Both the J domain and second zinc-binding motif interact with the intra-HEAT-repeat loops of HEAT repeats 3–7 of the A subunit, which overlaps with the binding site of the PP2A B56 subunit. Intriguingly, the first zinc-binding motif is in a position that may allow it to directly interact with and inhibit the phosphatase activity of the PP2A catalytic C subunit. These observations provide a structural basis for understanding the oncogenic functions of ST

The genetic architecture of the human cerebral cortex

The cerebral cortex underlies our complex cognitive capabilities, yet little is known about the specific genetic loci that influence human cortical structure. To identify genetic variants that affect cortical structure, we conducted a genome-wide association meta-analysis of brain magnetic resonance imaging data from 51,665 individuals. We analyzed the surface area and average thickness of the whole cortex and 34 regions with known functional specializations. We identified 199 significant loci and found significant enrichment for loci influencing total surface area within regulatory elements that are active during prenatal cortical development, supporting the radial unit hypothesis. Loci that affect regional surface area cluster near genes in Wnt signaling pathways, which influence progenitor expansion and areal identity. Variation in cortical structure is genetically correlated with cognitive function, Parkinson's disease, insomnia, depression, neuroticism, and attention deficit hyperactivity disorder

Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial

Aims The objective of the Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) was to determine whether aliskiren, a direct renin inhibitor, would improve post-discharge outcomes in patients with hospitalization for heart failure (HHF) with reduced ejection fraction. Pre-specified subgroup analyses suggested potential heterogeneity in post-discharge outcomes with aliskiren in patients with and without baseline diabetes mellitus (DM). Methods and results ASTRONAUT included 953 patients without DM (aliskiren 489; placebo 464) and 662 patients with DM (aliskiren 319; placebo 343) (as reported by study investigators). Study endpoints included the first occurrence of cardiovascular death or HHF within 6 and 12 months, all-cause death within 6 and 12 months, and change from baseline in N-terminal pro-B-type natriuretic peptide (NT-proBNP) at 1, 6, and 12 months. Data regarding risk of hyperkalaemia, renal impairment, and hypotension, and changes in additional serum biomarkers were collected. The effect of aliskiren on cardiovascular death or HHF within 6 months (primary endpoint) did not significantly differ by baseline DM status (P = 0.08 for interaction), but reached statistical significance at 12 months (non-DM: HR: 0.80, 95% CI: 0.64-0.99; DM: HR: 1.16, 95% CI: 0.91-1.47; P = 0.03 for interaction). Risk of 12-month all-cause death with aliskiren significantly differed by the presence of baseline DM (non-DM: HR: 0.69, 95% CI: 0.50-0.94; DM: HR: 1.64, 95% CI: 1.15-2.33; P < 0.01 for interaction). Among non-diabetics, aliskiren significantly reduced NT-proBNP through 6 months and plasma troponin I and aldosterone through 12 months, as compared to placebo. Among diabetic patients, aliskiren reduced plasma troponin I and aldosterone relative to placebo through 1 month only. There was a trend towards differing risk of post-baseline potassium ≥6 mmol/L with aliskiren by underlying DM status (non-DM: HR: 1.17, 95% CI: 0.71-1.93; DM: HR: 2.39, 95% CI: 1.30-4.42; P = 0.07 for interaction). Conclusion This pre-specified subgroup analysis from the ASTRONAUT trial generates the hypothesis that the addition of aliskiren to standard HHF therapy in non-diabetic patients is generally well-tolerated and improves post-discharge outcomes and biomarker profiles. In contrast, diabetic patients receiving aliskiren appear to have worse post-discharge outcomes. Future prospective investigations are needed to confirm potential benefits of renin inhibition in a large cohort of HHF patients without D

Open innovation in public management: analysis of the Brazilian action plan for Open Government Partnership

Este estudo objetivou analisar o Plano de Ação brasileiro para o Governo Aberto, baseado na teoria da inovação aberta na gestão pública. Utilizou-se de uma pesquisa documental, com vistas a aprofundar o conhecimento do fenômeno em questão. O documento foi escolhido intencionalmente, por ser exemplo basilar das políticas públicas relacionadas à inovação aberta brasileira. Os resultados mostram que os compromissos firmados pelo governo brasileiro estão consoantes com o processo de inovação aberta pública. As ações previstas no Plano estão especificamente relacionadas a transparência, abertura de dados e preparação do corpo estatal para o processo aberto de inovação. _________________________________________________________________________________________ RESUMEN: Este estudio tuvo como objetivo analizar el Plan de Acción de Brasil para el Gobierno Abierto con base en la teoría de la innovación abierta en la gestión pública. Se utilizó una investigación documental, con el fin de profundizar el conocimiento en el fenómeno en cuestión. El documento fue elegido intencionadamente porque es fundamental para las políticas públicas relacionadas con la innovación abierta brasileña. Los resultados muestran que los compromisos asumidos por el gobierno brasileño son compatibles con el proceso de innovación abierta pública. En concreto, las acciones contenidas en el plan están relacionados con la transparencia, los datos abiertos y preparación de la estructura de gobierno para el proceso abierto de innovación. _________________________________________________________________________________________ ABSTRACT: This study aims to analyze the Brazilian action plan for Open Government, based on the theory of open innovation in public management. Documentary research was used, in order to deepen of the knowledge the phenomenon being discussed . The document was intentionally chosen because it is essential for public policies related to Brazilian open innovation The results show that the commitments made by the Brazilian government are compatible with the public open innovation process. The actions in the Plan are related specifically to transparency, open data and preparation of the governance body for the open innovation process

The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase&nbsp;1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation&nbsp;disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age&nbsp; 6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score&nbsp; 652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc&nbsp;= 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N&nbsp;= 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in&nbsp;Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in&nbsp;Asia&nbsp;and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

Management Considerations for Designing Carnivore Highway Crossings

Many agencies are contemplating building wildlife crossings to reduce wildlife mortality, to improve habitat connectivity, and to reduce vehicle collisions. For this to occur without problems and interagency disagreements, relationships between agencies and key individuals must be well-developed. Once relationships are in-place highway improvements and wildlife habitat objectives are more easily integrated. The second step in coordinating wildlife issues with transportation is development of interagency statewide, regional or highway specific wildlife habitat linkage plans. These determine a number of critical factors necessary to locate wildlife crossings, prioritize opportunities and focus funding and personnel. To be effective, transportation, wildlife management and land management agencies must be involved in these plans. The third step involves choosing the appropriate location, structure type and structure size for target species. This process must take into consideration more than biological criteria and includes cost factors and construction feasibility issues born by highway agencies. Last, monitoring will help improve future wildlife crossing efforts and help all agencies and the public gain confidence in their effectiveness

Effects of highways on elk (Cervus elaphus) habitat in the Western United States and proposed mitigation approaches

Why Elk? Elk are an excellent species to use as a “terrestrial wildlife indicator” for highway impacts. First, they are widespread and exist in all western states as well as several midwestern and eastern states. They are prevalent on many National Forest lands, Bureau of Land Management lands, USDI Fish and Wildlife Service and National Park Service lands. Much elk habitat is on public lands in the western United States (Flathers and Hoekstra 1989, Peek undated, Thomas and Toweill 1982). Elk are also one of the best studied animals in North America. This is particularly true in respect to the effects of roads on elk. Very few wildlife species have as much scientific literature directed at them. Information such as food habits, density, behavior, fecundity, migration patterns, home range sizes and other important scientific data also abounds. Socially, elk are almost universally accepted as important native wildlife. They are generally not controversial, and their presence is usually accepted or even cherished. Economically, elk are one of the most important wildlife species in the western US. The economics of elk includes revenues to state wildlife agencies, motels, restaurants, airlines, and sporting goods manufacturers and retailers. Elk are enjoyed by the public for hunting, for food value, for viewing, and other aesthetic purposes